Document Detail

SCD in the world, Europe, Bosnia and Herzegovina and Mostar.
MedLine Citation:
PMID:  21548414     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: SCD remains one of the major public health problems in the world and is most commonly caused by CAD. Risk stratification is effective for groups, but difficult in case of individuals. There is a need for major improvements in prevention, risk protection, resuscitation and therapy.
Emir Fazlibegovic; Mustafa Hadziomerovic; Aziz Dedovic; Emir Veledar; Fadila Fazlibegovic
Related Documents :
7085454 - Noniatrogenic rectal tears in three horses.
10752424 - Endocarditis prophylaxis.
8865984 - Embolic stroke in a pregnant patient with a mechanical heart valve on optimal heparin t...
18473864 - Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneo...
10502224 - Correlation between clinical and doppler echocardiographic findings in patients with mo...
20005994 - Concomitant left anterior descending coronary artery and right coronary artery occlusio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medicinski arhiv     Volume:  61     ISSN:  0350-199X     ISO Abbreviation:  Med Arh     Publication Date:  2007  
Date Detail:
Created Date:  2011-05-09     Completed Date:  2011-07-20     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0400722     Medline TA:  Med Arh     Country:  Bosnia and Hercegovina    
Other Details:
Languages:  eng     Pagination:  23-6     Citation Subset:  IM    
Clinical Hospital Mostar, Clinic of Internal Medicine, Department of Cardiology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bosnia-Herzegovina / epidemiology
Death, Sudden, Cardiac / epidemiology*
Europe / epidemiology
Middle Aged

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Left bundle branch block (LBBB) in patients with heart failure (HF) in Mostar region of Bosnia and H...
Next Document:  The evolution of percutaneous coronary intervention: from balloons to drug eluting stents.